Literature DB >> 5415676

Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction.

M M Kaplan, A Righetti.   

Abstract

Bile duct ligation in the rat leads to a rapid increase in hepatic and serum alkaline phosphatase activity. Within 12 hr after bile duct ligation, hepatic alkaline phosphatase has increased 7-fold and serum alkaline phosphatase activity 2(1/2)-fold. The elevation in the serum activity is completely due to an increase in an isozyme that appears to originate in the liver. This serum isozyme and liver phosphatase, both partially purified by DEAE-cellulose column chromatography, have identical Michaelis constants, pH optima, and rates of heat denaturation. These isozymes migrate identically when subjected to electrophoresis on polyacrylamide gel, and their migration rates are equally slowed after neuraminidase digestion. The data suggest that the rise in hepatic alkaline phosphatase activity is dependent on de novo protein synthesis. Cycloheximide, in a dose that inhibited incorporation of leucine-(14)C into protein by 68%, inhibited the rise in liver phosphatase by 98% and that in serum by 80%. The rise in liver phosphatase activity could not be accounted for by simple retention of alkaline phosphatase that would normally appear in bile. The rise in liver activity after bile duct ligation was 240 times greater than the amount of phosphatase that normally appears in bile over a similar period of time. Cycloheximide had no effect on the bile duct ligation-induced changes in the serum and liver glutamic pyruvic transaminase.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5415676      PMCID: PMC322498          DOI: 10.1172/JCI106260

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  SOURCE OF THE ELEVATED SERUM ALKALINE PHOSPHATASE ACTIVITY IN BILIARY OBSTRUCTION: STUDIES UTILIZING ISOLATED LIVER PERFUSION.

Authors:  D G SEBESTA; F J BRADSHAW; D J PROCKOP
Journal:  Gastroenterology       Date:  1964-08       Impact factor: 22.682

2.  Iso-enzymes of alkaline phosphatase.

Authors:  A W HODSON; A L LATNER; L RAINE
Journal:  Clin Chim Acta       Date:  1962-03       Impact factor: 3.786

3.  Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. A consideration of the current status.

Authors:  A B GUTMAN
Journal:  Am J Med       Date:  1959-12       Impact factor: 4.965

4.  The purification of aklaline phosphatases of animal tissues.

Authors:  R K MORTON
Journal:  Biochem J       Date:  1954-08       Impact factor: 3.857

5.  The origin of elevation of serum alkaline phosphatase in hepatic disease. An experimental study.

Authors:  S G POLIN; M A SPELLBERG; L TEITELMAN; M OKUMURA
Journal:  Gastroenterology       Date:  1962-04       Impact factor: 22.682

6.  Separation of human serum-alkaline-phosphatase isoenzymes by polyacrylamide gel electrophoresis.

Authors:  M M Kaplan; L Rogers
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

Review 7.  Alkaline phosphatase.

Authors:  S Posen
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

8.  Induction of liver alkaline phosphatase by bile duct ligation.

Authors:  M M Kaplan; A Righetti
Journal:  Biochim Biophys Acta       Date:  1969-09-02

9.  The behavior of infused human placental alkaline phosphatase in human subjects.

Authors:  J S Clubb; F C Neale; S Posen
Journal:  J Lab Clin Med       Date:  1965-09

10.  Studies on the mechanism of hormone induction of alkaline phosphatase in human cell cultures, II. Rate of enzyme synthesis and properties of base level and induced enzymes.

Authors:  M J Griffin; R P Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

View more
  35 in total

Review 1.  The scientific foundations of clinical enzymology.

Authors:  D W Moss
Journal:  Naturwissenschaften       Date:  1977-05

2.  An interpretation of the serum alkaline phosphatase isoenzyme patterns in patients with obstructive liver disease.

Authors:  C P Price; H G Sammons
Journal:  J Clin Pathol       Date:  1976-11       Impact factor: 3.411

3.  Misleading SGOT (aspartate aminotransferase) values in obstructive jaundice due to pancreatic carcinoma.

Authors:  P B Gregory; D P Cooney
Journal:  Am J Dig Dis       Date:  1976-06

4.  Bile enzyme activities in patients with T-tube drainage following cholecystectomy.

Authors:  P R Baker; A Cuschieri
Journal:  Br J Exp Pathol       Date:  1978-06

Review 5.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

6.  Effects of fermented Sorghum bicolor L. Moench extract on inflammation and thickness in a vascular cell and atherosclerotic mice model.

Authors:  Young Min Ham; Hae Seong Song; Jeong Eun Kwon; Hyelin Jeon; Hyun Jin Baek; Chang Won Kim; Weon-Jong Yoon; Eui Su Choung; Se Chan Kang
Journal:  J Nat Med       Date:  2018-07-31       Impact factor: 2.343

Review 7.  Multiple forms of alkaline phosphatase: some topics of current interest.

Authors:  D W Moss
Journal:  Histochem J       Date:  1974-07

Review 8.  Alkaline phosphatase.

Authors:  T W Warnes
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

9.  Electron microscopic studies on hepatic alkaline phosphatase in experimentally induced biliary obstruction of the rat.

Authors:  M Kako; G Toda; M Torii; H Kimura; K Miyake; H Suzuki; T Oda
Journal:  Gastroenterol Jpn       Date:  1980

10.  Serum -glytamyl transpeptidase activity in liver disease.

Authors:  J B Whitfield; R E Pounder; G Neale; D W Moss
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.